Pain Management Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

PAIN MANAGEMENT

Permanent storage and easy retrieval of Journal articles and formulations.
  - Includes the full-color, searchable, PDF files of articles and formulations from the Journal.
  - Print Journal articles in color for your research and marketing needs.
  - Eliminate long searches through past issues for articles and formulations.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

(Select Format)

This archive contains the following articles listed by volume, issue and page number:

Title (Click for Details)	Vol/Issue	Page

PAIN MANAGEMENT RELATED ARTICLES
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin	Vol. 22 No. 6	498
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1	Vol. 22 No. 4	284
Ketoprofen 10% in Pluronic Lecithin Organogel	Vol. 22 No. 4	319
Kinetics of Tetracaine Solvolysis in Propylene Glycol	Vol. 22 No. 4	329
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension	Vol. 22 No. 3	235
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia	Vol. 22 No. 3	252
Prochlorperazine Edisylate 0.5% Nasal Spray	Vol. 22 No. 2	150
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome	Vol. 22 No. 2	172
Pain: Systematic Review of Pharmacy Compounding of Pain Medication	Vol. 22 No. 1	19
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF	Vol. 22 No. 1	54
Tolmetin 400-mg Capsules	Vol. 21 No. 6	497
Compounding Opportunities in Urology	Vol. 21 No. 5	358
Fentanyl Citrate 50-mcg/mL Injection	Vol. 21 No. 5	411
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel	Vol. 21 No. 4	314
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia	Vol. 21 No. 4	347
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base	Vol. 21 No. 3	234
Meloxicam 1% Topical Gel	Vol. 21 No. 3	235
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs	Vol. 21 No. 2	164
Nifedipine 0.5% Rectal Ointment	Vol. 21 No. 1	63
Tetracaine Hydrochloride 0.5% Ophthalmic Solution	Vol. 21 No. 1	64
Calculations	Vol. 20 No. 6	502
Capsaicin 0.025% and Doxepin 3.3% Cream	Vol. 20 No. 6	506
Melatonin 2-mg/mL Oral Suspension	Vol. 20 No. 6	512
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment	Vol. 20 No. 6	513
Stability of Fentanyl Citrate in Polyolefin Bags	Vol. 20 No. 6	514
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial	Vol. 20 No. 6	517
Naproxen 5% Cream	Vol. 20 No. 5	410
Tetracaine Hydrochloride 2% Topical Solution	Vol. 20 No. 5	414
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients	Vol. 20 No. 3	197
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm	Vol. 20 No. 3	231
Pain-Away II Headache Capsules	Vol. 20 No. 3	233
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children	Vol. 20 No. 3	247
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives	Vol. 20 No. 3	250
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future	Vol. 20 No. 2	107
Blue Goo Anti-Itch Gel	Vol. 20 No. 2	144
Medicated Polyox Bandage for Skin Ulcers	Vol. 20 No. 2	146
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray	Vol. 20 No. 2	147
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm	Vol. 20 No. 1	50
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules	Vol. 19 No. 6	504
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review	Vol. 19 No. 4	295
Proparacaine Hydrochloride 0.5% Ophthalmic Solution	Vol. 19 No. 4	332
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution	Vol. 19 No. 3	243
Phenazopyridine Hydrochloride 200-mg Capsules	Vol. 19 No. 3	245
Physostigmine Salicylate 1-mg/mL Injection	Vol. 19 No. 3	246
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles	Vol. 19 No. 3	268
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution	Vol. 19 No. 2	148
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations	Vol. 19 No. 2	161
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time	Vol. 19 No. 2	167
Lidocaine Hydrochloride 4% Topical Solution	Vol. 19 No. 1	67
Skin Penetration and Antinociception of Topical Gabapentin Formulations	Vol. 18 No. 6	504
Sumatriptan Succinate 12-mg/mL Injection	Vol. 18 No. 5	416
Compounded Pain Formulations: What is the Evidence?	Vol. 18 No. 4	278
Atracurium Besylate 10-mg/mL Injection, Preserved	Vol. 18 No. 4	322
Choline Magnesium Trisalicylate Liquid	Vol. 18 No. 4	327
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications	Vol. 18 No. 3	182
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice	Vol. 18 No. 3	190
Bupivacaine Hydrochloride 0.5% Injection	Vol. 18 No. 3	234
Butorphanol Tartrate 10-mg/mL Nasal Spray	Vol. 18 No. 3	235
Dibucaine 1% Ointment	Vol. 18 No. 3	236
Lidocaine Hydrochloride 1% Injection	Vol. 18 No. 3	237
Naproxen 25-mg/mL Oral Suspension	Vol. 18 No. 3	239
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery	Vol. 18 No. 3	256
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report	Vol. 18 No. 1	14
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C	Vol. 18 No. 1	78
Dihydroergotamine Mesylate 1-mg/mL Injection	Vol. 17 No. 6	503
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles	Vol. 17 No. 6	508
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream	Vol. 17 No. 6	520
Indomethacin 1-mg/mL Injection	Vol. 17 No. 5	419
Ketamine 50-mg/mL Injection	Vol. 17 No. 4	331
Methohexital Sodium 500-mg/mL Injection	Vol. 17 No. 4	332
Buffered Aspirin Capsules	Vol. 17 No. 3	228
Naltrexone Hydrochloride 50-mg Capsules	Vol. 17 No. 3	235
Alcohol Dehydrated Injection	Vol. 17 No. 2	145
Ibuprofen 10-mg/mL Injection	Vol. 17 No. 1	67
Mepivacaine Hydrochloride 1% Injection	Vol. 17 No. 1	68
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act	Vol. 16 No. 6	446
Palliative Care and Compounding for Household Pets	Vol. 16 No. 6	452
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents	Vol. 16 No. 6	462
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules	Vol. 16 No. 6	506
Vercuronium Bromide 1-mg/mL Injection	Vol. 16 No. 6	509
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report	Vol. 16 No. 5	364
Meperidine Hydrochloride 50-mg/mL Injection	Vol. 16 No. 5	423
Methocarbamol 100-mg/mL Injection	Vol. 16 No. 5	424
Nalbuphine Hydrochloride 10-mg/mL Injection	Vol. 16 No. 5	426
Oxymorphone Hydrochloride 1-mg/mL Injection	Vol. 16 No. 5	427
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date	Vol. 16 No. 5	428
A Concise Discussion of Headache Types, Part 3: Migraine	Vol. 16 No. 4	270
Butorphanol Tartrate 2-mg/mL Injection	Vol. 16 No. 4	333
Ketorolac Tromethamine 15-mg/mL Injection	Vol. 16 No. 4	337
Sufentanil Citrate 50-mcg/mL Injection	Vol. 16 No. 4	340
A Concise Discussion of Headache Types, Part 2: Migraine	Vol. 16 No. 3	182
Burning Mouth Syndrome: A Discussion of a Complex Pathology	Vol. 16 No. 3	196
Alfentanil 500-mcg/mL Injection	Vol. 16 No. 3	239
A Concise Discussion of Headache Types, Part 1	Vol. 16 No. 2	125
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection	Vol. 16 No. 2	155
Caffeine Citrate 20-mg/mL Injection	Vol. 16 No. 2	156
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method	Vol. 16 No. 2	170
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management	Vol. 16 No. 1	22
Case Studies of Compounded Tramadol Use in Cats	Vol. 16 No. 1	44
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion	Vol. 15 No. 6	504
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions	Vol. 15 No. 5	376
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient	Vol. 15 No. 5	386
Transdermals: The Skin as Part of a Drug Delivery System	Vol. 15 No. 4	308
Anesthetic Nasal Ointment	Vol. 15 No. 4	334
Oxandrolone 1-mg/mL Oral Suspension	Vol. 15 No. 4	341
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient	Vol. 15 No. 3	194
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel	Vol. 15 No. 3	242
Diclofenac Sodium 1% Topical Gel	Vol. 15 No. 3	243
Ibuprofen 5% Topical Cream	Vol. 15 No. 3	244
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel	Vol. 15 No. 3	245
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel	Vol. 15 No. 2	157
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine	Vol. 15 No. 2	174
Current Concepts in the Treatment of Recurrent Aphthous Ulcers	Vol. 15 No. 1	13
Toxicities Associated with Topical Anesthetics	Vol. 15 No. 1	41
Diclofenac Sodium 10-mg/mL Oral Suspension	Vol. 15 No. 1	64
Ibuprofen 5% Gel	Vol. 15 No. 1	66
Piroxicam 1% Gel	Vol. 15 No. 1	69
Pramoxine 1% Cream	Vol. 15 No. 1	70
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding	Vol. 14 No. 6	484
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel	Vol. 14 No. 6	512
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel	Vol. 14 No. 6	513
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel	Vol. 14 No. 6	514
Capsaicin 0.05% Clear Medication Stick	Vol. 14 No. 6	517
Ketoprofen 2% Oral Gel	Vol. 14 No. 6	521
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care	Vol. 14 No. 6	480
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel	Vol. 14 No. 6	520
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients	Vol. 14 No. 5	395
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection	Vol. 14 No. 5	427
Polidocanol 0.5% Wound Spray	Vol. 14 No. 5	429
Acyclovir with Benzocaine Lip Balm	Vol. 14 No. 4	332
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone	Vol. 14 No. 4	333
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser	Vol. 14 No. 4	310
Buprenorphine Hydrochloride Injection	Vol. 14 No. 4	337
Chloroprocaine Hydrochloride Injection	Vol. 14 No. 4	338
Flurbiprofen 5% Bioadhesive Gel for Gingivitis	Vol. 14 No. 4	341
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome	Vol. 14 No. 3	182
Topical Medications for Orofacial Neuropathic Pain	Vol. 14 No. 3	200
Managing Pain with Transdermal Ketoprofen	Vol. 14 No. 3	204
Potential Treatments for Radiation Dermatitis	Vol. 14 No. 3	210
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report	Vol. 14 No. 3	215
Calculations	Vol. 14 No. 3	230
Carprofen 2.5-mg/mL Oral Suspension, Veterinary	Vol. 14 No. 3	241
Celecoxib 10-mg/mL Oral Suspension	Vol. 14 No. 3	242
The Role of Sex Hormones on Fibromyalgia Pain Mediators	Vol. 14 No. 3	193
Cohen's Rectal Ointment	Vol. 14 No. 3	244
Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector	Vol. 14 No. 2	160
Tetracaine 4% and Menthol 5% Topical Gel	Vol. 14 No. 1	73
Trigger Point Gel	Vol. 14 No. 1	75
Topiramate 6-mg/mL Oral Suspension	Vol. 13 No. 6	560
Aceclofenac 1.5% Pluronic Lecithin Organogel	Vol. 13 No. 5	428
An Abridged History of Aspirin	Vol. 13 No. 5	404
Lidocaine 10% Oral Pluronic Lecithin Organogel	Vol. 13 No. 5	433
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications	Vol. 13 No. 5	400
Update on Managing Neuropathic Pain	Vol. 13 No. 3	182
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids	Vol. 13 No. 3	192
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report	Vol. 13 No. 3	196
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers	Vol. 13 No. 3	214
Safe Use of Topical Local Anesthetic Medications for Pain Management	Vol. 13 No. 3	218
Calculations	Vol. 13 No. 3	239
Analgesic Compound Lotion, Clear	Vol. 13 No. 3	240
Hydromorphone Hydrochloride 10-mg/mL Oral Drops	Vol. 13 No. 3	241
Lidocaine 2% Popsicle	Vol. 13 No. 3	242
Morphine Sulfate 10-mg/mL Oral Solution	Vol. 13 No. 3	243
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel	Vol. 13 No. 3	244
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel	Vol. 13 No. 3	245
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules	Vol. 13 No. 3	246
Oxycodone Hydrochloride 20-mg Suppository	Vol. 13 No. 3	247
Promethazine 20-mg and Acetaminophen 325-mg Suppositories	Vol. 13 No. 3	248
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules	Vol. 13 No. 3	249
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel	Vol. 13 No. 1	66
Tetracaine 0.025% Popsicles	Vol. 13 No. 1	73
Equine Anesthesia: Triple Drip	Vol. 12 No. 5	402
Aceclofenac 1.5% Gel-Cream	Vol. 12 No. 5	446
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration	Vol. 12 No. 5	463
Acetaminophen 10-mg/mL Rectal Solution	Vol. 12 No. 5	447
Ketoprofen 20% Topical Solution	Vol. 12 No. 5	452
Lidocaine Adhesive System Gel	Vol. 12 No. 5	453
Piroxicam 5% and Dexpanthenol 5% Gel	Vol. 12 No. 5	454
Case Reports: Compounding to Relieve Arthritis Pain	Vol. 12 No. 6	498
Glycerin, Sterile	Vol. 12 No. 6	542
Indomethacin 2% in Pluronic Lecithin Organogel	Vol. 12 No. 6	543
Ketorolac Tromethamine 2% Topical Gel	Vol. 12 No. 6	544
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel	Vol. 12 No. 6	540
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel	Vol. 12 No. 6	541
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches	Vol. 12 No. 6	549
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration	Vol. 12 No. 6	553
Standard Operating Procedure: Dealing with Patients Experiencing Pain: Presenting without a Prescription	Vol. 12 No. 3	259
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel	Vol. 12 No. 3	266
PreScription: Pain!	Vol. 12 No. 3	180
Topical Treatment of Neuropathic Pain	Vol. 12 No. 3	182
Compounded Local Anesthetics to Minimize Pain from Medical Procedures	Vol. 12 No. 3	192
Dilution and Compounding of Ziconotide for Intrathecal Administration	Vol. 12 No. 3	200
Developing a Niche Marketing Strategy	Vol. 12 No. 3	242
Chemical Stability of Tramadol Hydrochloride Injection	Vol. 12 No. 2	161
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting	Vol. 12 No. 2	163
Carbamazepine Topical Preparations	Vol. 12 No. 2	150
Hospice and Compounding Pharmacy: Once Inseperable	Vol. 12 No. 1	28
Diclofenac Sodium 1% Soft-Patch Gel	Vol. 12 No. 1	65
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel	Vol. 12 No. 1	66
Flosulide 10-mg/mL Injection	Vol. 12 No. 1	69
Piroxicam 1% Soft-Patch Lipophilic Gel	Vol. 12 No. 1	71
Piroxicam 1% Soft-Patch Topical Gel	Vol. 12 No. 1	72
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen	Vol. 11 No. 6	514
Lidocaine Hydrochloride 1.82% Buffered Injection	Vol. 11 No. 6	511
Rabbit Medicine	Vol. 11 No. 5	364
Diclofenac Sodium 75-mg/mL Injection	Vol. 11 No. 5	421
Hydrocortisone 0.5% Ethanolic Gel	Vol. 11 No. 5	423
Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution	Vol. 11 No. 4	328
Mebeverine Hydrochloride 20% gel	Vol. 11 No. 4	330
Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution	Vol. 11 No. 4	335
Levorphanol for Excruciating Pain from Oral Cancer: A Case Report	Vol. 11 No. 3	212
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2	Vol. 11 No. 3	220
Calculations - Compounding for Pain Management	Vol. 11 No. 3	238
Transdermal Gel in the Treatment of Postoperative Pain	Vol. 11 No. 3	181
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited	Vol. 11 No. 3	187
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids	Vol. 11 No. 3	194
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain	Vol. 11 No. 3	200
Levorphanol for the Treatment of Severe Chronic Pain	Vol. 11 No. 3	202
Aspirin 80-mg/5-mL Oral Liquid, Anhydrous	Vol. 11 No. 2	154
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster	Vol. 11 No. 2	131
Principles of Pediatric Palliative Care and Pain Control	Vol. 11 No. 1	10
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid	Vol. 11 No. 1	71
Dexamethasone 1-mg/mL Oral Liquid	Vol. 11 No. 1	72
Chloral Hydrate 50-mg/mL Oral Liquid	Vol. 10 No. 6	453
Gabapentin 100-mg/mL Oral Liquid	Vol. 10 No. 6	456
Indomethacin 2-mg/mL Oral Liquid	Vol. 10 No. 6	458
Migraine: A General Approach to Prevention and Treatment	Vol. 10 No. 5	344
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches	Vol. 10 No. 5	351
Midazolam Hydrochloride 1-mg/mL Oral Liquid	Vol. 10 No. 5	387
Hospice Symptom Relief Kit: An Update	Vol. 10 No. 4	288
Tramadol Hydrochloride 5-mg/mL Oral Liquid	Vol. 10 No. 4	307
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid	Vol. 10 No. 4	308
Mexiletine Hydrochloride 10-mg/mL Oral Suspension	Vol. 10 No. 3	225
Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together	Vol. 10 No. 3	237
Chemical Stability of Diclofenac Sodium Injection	Vol. 10 No. 2	154
PostScription: Treatment of Chronic Pain with Methadone or Levorphanol	Vol. 10 No. 2	159
Hospice from a Compounding Pharmacist's Perspective	Vol. 10 No. 2	89
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh	Vol. 10 No. 1	9
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery	Vol. 10 No. 1	14
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid	Vol. 10 No. 1	66
Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management	Vol. 10 No. 1	69
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags	Vol. 9 No. 6	482
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain	Vol. 9 No. 5	339
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain	Vol. 9 No. 5	349
A Patient's Guide to Transdermal Treatment of Pain	Vol. 9 No. 5	354
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules	Vol. 9 No. 5	386
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules	Vol. 9 No. 5	387
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules	Vol. 9 No. 5	388
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules	Vol. 9 No. 5	389
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection	Vol. 9 No. 5	390
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules	Vol. 9 No. 5	391
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules	Vol. 9 No. 5	392
Methadone Hydrochloride 0.33-mg/mL Oral Solution	Vol. 9 No. 5	393
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection	Vol. 9 No. 5	394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary)	Vol. 9 No. 5	395
Bonain's Solution	Vol. 9 No. 4	311
Brompton's Mixture	Vol. 9 No. 4	312
Dexamethasone Oral Powder 10-mg Units, Veterinary	Vol. 9 No. 3	226
Dipyrone 500-mg/mL Injection, Veterinary	Vol. 9 No. 3	227
Meloxicam 0.2 mg/mL Oral Liquid, Veterinary	Vol. 9 No. 3	228
Piroxicam 2-mg/mL Oral Liquid, Veterinary	Vol. 9 No. 3	234
Capsaicin 0.2-mg Troches	Vol. 9 No. 2	148
Clobetasol and Dyclonine Oral Paste	Vol. 9 No. 2	150
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride	Vol. 9 No. 2	157
Amitriptyline Hydrochloride 10-mg/mL Injection	Vol. 9 No. 1	62
Fentanyl 15-mg/mL Injection, Preservative Free	Vol. 9 No. 1	63
Gabapentin 2-mg/mL Injection, Preservative Free	Vol. 9 No. 1	64
Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection	Vol. 9 No. 1	66
Naproxen Sodium 100-mg/mL Injection	Vol. 9 No. 1	68
Phenol 8% Injection	Vol. 9 No. 1	69
Tolazoline Hydrochloride 25-mg/mL Injection	Vol. 9 No. 1	70
Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free	Vol. 9 No. 1	71
Compounding for Sports Medicine	Vol. 8 No. 6	443
Diclofenac Sodium 25-mg/mL Injection	Vol. 8 No. 6	470
Ketamine Hydrochloride and Fentanyl Citrate Injection	Vol. 8 No. 6	474
Ketamine 25-mg/mL Nasal Spray	Vol. 8 No. 6	475
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray	Vol. 8 No. 6	476
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink	Vol. 8 No. 6	489
Book and Literature Reviews	Vol. 8 No. 5	324
Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications	Vol. 8 No. 5	337
Diclofenac Sodium 1.5% Topical Gel	Vol. 8 No. 5	387
Ibuprofen 2% Topical Gel	Vol. 8 No. 5	388
Book and Literature Reviews	Vol. 8 No. 4	244
Migraine Headache Suppositories	Vol. 8 No. 3	184
Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches	Vol. 8 No. 3	184
Morphine Sulfate 5-mg/0.1-mL Nasal Spray	Vol. 8 No. 3	185
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO)	Vol. 8 No. 3	185
Pain Management in the Elderly	Vol. 8 No. 3	187
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base)	Vol. 8 No. 3	208
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base)	Vol. 8 No. 3	208
Emollient Lip Balm with 5% Benzocaine	Vol. 8 No. 3	208
Fever Blister Ointment	Vol. 8 No. 3	208
Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream	Vol. 8 No. 3	208
Acyclovir 5% and Lidocaine HCl 2% Topical Gel	Vol. 8 No. 3	209
Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel	Vol. 8 No. 3	209
Acyclovir 5% and Dexamethasone 0.1% Topical Gel	Vol. 8 No. 3	209
Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel	Vol. 8 No. 3	209
Clonidine HCl 1.5-mg/mL Injection	Vol. 8 No. 3	216
Ketoprofen 50-mg Suppository	Vol. 8 No. 3	219
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection	Vol. 8 No. 3	220
Sumatriptan 25-mg Suppository	Vol. 8 No. 3	221
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs	Vol. 8 No. 2	101
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection	Vol. 8 No. 2	136
Sore Nipples in Breastfeeding Mothers: Causes and Treatments	Vol. 7 No. 6	426
Methadone HCl 2.5-mg Capsules	Vol. 7 No. 6	472
Tramadol HCl 100-mg Capsules	Vol. 7 No. 6	475
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers	Vol. 7 No. 6	481
Indomethacin 50-mg Suppositories	Vol. 7 No. 5	375
Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules	Vol. 7 No. 5	377
Phenylbutazone 100-mg Capsules	Vol. 7 No. 5	379
Basics of Compounding for Raynaud's Disease	Vol. 7 No. 4	288
Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection	Vol. 7 No. 4	300
Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection	Vol. 7 No. 4	301
Methocarbamol 400-mg and Aspirin 325-mg Capsules	Vol. 7 No. 4	302
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP	Vol. 7 No. 3	180
Dexamethasone Phosphate 0.1% Topical Cream	Vol. 7 No. 3	216
Ergotamine Tartrate 2-mg Sublingual Tablets	Vol. 7 No. 3	219
Methadone HCl 5-mg/mL Injection	Vol. 7 No. 3	221
Ketoprofen 10% in PLO	Vol. 7 No. 3	183
Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO	Vol. 7 No. 3	171
PostScription: Sterile Product Admixture Preparation	Vol. 7 No. 2	160
Dexamethasone Sodium Phosphate 4-mg/mL Injection	Vol. 6 No. 6	450
Hydromorphone HCl 0.1-mg/mL Injection for Patient-Controlled Analgesia	Vol. 6 No. 6	454
Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection	Vol. 6 No. 6	455
Morphine Sulfate 2-mg/mL and Droperidol 0.08-mg/mL Injection for Patient-Controlled Analgesia	Vol. 6 No. 6	456
Drug Therapy for Acute and Chronic Pain in the Cat	Vol. 6 No. 5	338
Basics of Compounding: Phonophoresis	Vol. 6 No. 5	362
Ketoprofen 2% Gel for Phonophoresis	Vol. 6 No. 5	364
Naproxen 5% Gel for Phonophoresis	Vol. 6 No. 5	364
Sodium Salicylate 10% Gel for Phonophoresis	Vol. 6 No. 5	364
Hydrocortisone 10% Gel for Phonophoresis	Vol. 6 No. 5	364
Dexamethasone 1.5% and Lidocaine HCl 4% Ultrasound Gel	Vol. 6 No. 5	365
Ketoprofen 10% in Pluronic Lecithin Organogel	Vol. 6 No. 5	368
Basics of Compounding for Iontophoresis, Part II	Vol. 6 No. 4	288
Lidocaine HCl 4% Solution for Iontophoresis	Vol. 6 No. 4	290
Dexamethasone 4-mg/mL Solution for Iontophoresis	Vol. 6 No. 4	290
Acetic Acid 2% Solution for Iontophoresis	Vol. 6 No. 4	290
Ketorolac 6-mg/mL Solution for Iontophoresis	Vol. 6 No. 4	291
Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam	Vol. 6 No. 3	189
Basics of Compounding: Iontophoresis, Part 1	Vol. 6 No. 3	194
Camphor, Menthol, and Eucalyptol Rubefacient Ointment	Vol. 6 No. 3	201
Ergoloid Mesylates 15-mg/mL and Selegiline HCl 6.25-mg/mL in PLO	Vol. 6 No. 3	203
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance	Vol. 6 No. 1	4
Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective	Vol. 6 No. 1	13
Excerpts from and Reviews of Current Published Literature: Pain Management and Disorders of the Oral Cavity	Vol. 6 No. 1	19
Analgesic NSAID Suppositories	Vol. 6 No. 1	40
Capsaicin 0.075% Topical Spray	Vol. 6 No. 1	41
Clonidine HCl 0.2%, Gabapentin 6%, and Ketamine HCl 10% in a Pluronic Lecithin Organogel (PLO)	Vol. 6 No. 1	42
Diltiazem HCl 2% Topical Gel	Vol. 6 No. 1	43
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection	Vol. 6 No. 1	44
Fentanyl 100-mcg/0.1-mL in a Pluronic Lecithin Organogel (PLO)	Vol. 6 No. 1	45
Ketoprofen 12.5-mg, Phenyltoloxamine Citrate 30-mg, and Caffeine 30-mg Capsules	Vol. 6 No. 1	46
Morphine Sulfate 0.01%-Infused Silver Sulfadiazine (MISS) Cream	Vol. 6 No. 1	47
Morphine Sulfate 5-mg/0.1-mL Nasal Spray	Vol. 6 No. 1	48
Oxycodone 25-mg Slow-Release Capsules	Vol. 6 No. 1	49
Hydrocortisone 10% Phonophoresis Gel	Vol. 5 No. 6	454
Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution	Vol. 5 No. 6	455
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release	Vol. 5 No. 5	401
Sclerotherapy Injections of Phenol for Pain Management	Vol. 5 No. 4	308
PostScription: Case Reports and Formulations, George Roentsch, RPh.	Vol. 5 No. 2	160
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel	Vol. 5 No. 1	44
Fentanyl Troche Protocol	Vol. 4 No .6	447
Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel	Vol. 4 No. 5	377
Ketamine for Pain in Hospice Patients	Vol. 4 No. 4	253
Custom-Making Medications for the Hospice Patient	Vol. 4 No. 4	255
Surviving Cancer - How the Compounding Pharmacist Can Help	Vol. 4 No. 4	257
Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO	Vol. 4 No. 4	299
Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution	Vol. 4 No. 4	300
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers	Vol. 4 No. 4	301
Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection	Vol. 4 No. 4	303
Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs	Vol. 4 No. 4	318
Ketamine HCl 5% and Amitriptyline HCl 2% in PLO	Vol. 4 No. 2	132
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO	Vol. 4 No. 2	133
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium	Vol. 4 No. 1	6
The Psychology of Pain	Vol. 4 No. 1	12
Opioids: A Review of the Pharmacology	Vol. 4 No. 1	17
Fibromyalgia	Vol. 4 No. 1	21
Compounding Intrathecal Medications	Vol. 4 No. 1	24
Postherpetic Neuralgia	Vol. 4 No. 1	27
Amitriptyline HCl 2% and Baclofen 2% in PLO	Vol. 4 No. 1	50
Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO	Vol. 4 No. 1	51
Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream	Vol. 4 No. 1	52
Clonidine HCl 1-mg/g in VanPen Cream	Vol. 4 No. 1	53
Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel	Vol. 4 No. 1	54
Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches	Vol. 4 No. 1	55
Fentanyl 50-mcg Chewable Gummy Gels	Vol. 4 No. 1	56
Fentanyl 25-mcg/0.1-mL Nasal Spray	Vol. 4 No. 1	57
Morphine Sulfate 2.5-mg/mL Inhalation Solution	Vol. 4 No. 1	58
Shingles Ointment/Cream	Vol. 4 No. 1	59
Osteoarthritis: Other Options	Vol. 3 No. 6	433
Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player	Vol. 3 No. 6	441
Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis	Vol. 3 No. 6	441
Capsicum and Capsaicin Formulas	Vol. 3 No. 6	468
DMSO 70% Topical Solution	Vol. 3 No. 6	469
Glucosamine HCl 600-mg Capsules	Vol. 3 No. 6	470
Indomethacin 4% Topical Spray	Vol. 3 No. 6	471
Iontophoresis Solutions for Arthritis	Vol. 3 No. 6	472
Ketoprofen 2.5% in Pluronic Lecithin Organogel	Vol. 3 No. 6	473
Methyl Salicylate and Menthol Analgesic Stick	Vol. 3 No. 6	475
Piroxicam 1% Alcoholic Gel	Vol. 3 No. 6	476
Ultrasonic Preparations for Arthritis	Vol. 3 No. 6	477
Compounding for Athletes: Successful Sports Compounds	Vol. 3 No. 5	382
The Basics of Compounding: Compounding Gels	Vol. 3 No. 5	385
Piroxicam 0.5% in an Alcoholic Gel	Vol. 3 No. 5	389
Pluronic Lecithin Organogel (PLO Gel)	Vol. 3 No. 5	389
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules	Vol. 3 No. 5	409
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration	Vol. 3 No. 4	301
Morphine Sulfate 50-mg/mL Injection	Vol. 3 No. 4	302
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations	Vol. 3 No. 4	321
Compounding for Athletes: Tips for Making the Team	Vol. 3 No. 3	206
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill	Vol. 3 No. 3	215
Compounding for Athletes: A Primer for Rookies	Vol. 3 No. 2	104
The Basics of Compounding: Compounding Creams and Lotions	Vol. 3 No. 2	111
Athletic-Analgesic Rub	Vol. 3 No. 2	130
Piroxicam 0.5% in Pluronic Lecithin Organogel	Vol. 3 No. 2	133
The Basics of Compounding: Compounding Ointments and Pastes	Vol. 3 No. 1	22
Topical Ketoprofen for Fibromyalgia	Vol. 2 No. 6	433
Ketorolac tromethamine and Ketoprofen suppositories: release profiles and bioavailability of cocoa butter base formula in rabbits	Vol. 2 No. 5	390
Antipruritus Suspension (Stop Itch)	Vol. 2 No. 4	277
Benzocaine 2% Anesthetic Gel	Vol. 2 No. 4	296
Cocaine-Phenol-Tannic Acid Ointment	Vol. 2 No. 4	298
Compounding for Pain Management	Vol. 2 No. 2	104
Opioids for Noncancer Pain: From Controversy to Consensus	Vol. 2 No. 2	106
Phonophoresis with Hydrocortisone 10% in a Highly Viscous Complant Base	Vol. 2 No. 2	110
Managing Pain in the Terminally Ill	Vol. 2 No. 2	111
The Symptom Relief Kit for Hospice Patients	Vol. 2 No. 2	116
Dextromethorphan Hydrobromide and Opioid Tolerance: A Compounding Opportunity for Pharmacists with Chronic Pain Patients	Vol. 2 No. 2	118
Profile of a Practice/Patient Handout: DHE Nasal Spray	Vol. 2 No. 2	120
Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain	Vol. 2 No. 2	122
Buprenorphine HCl 150-mcg/100 mcL Nasal Spray	Vol. 2 No. 2	145
Capsaicin 0.05% Topical Gel	Vol. 2 No. 2	146
Dexamethasone Sodium Phosphate 1-mg/mL for Iontophoresis	Vol. 2 No. 2	147
Dextromethorphan Hydrobromide 30-mg and Morphine Sulfate 10-mg Capsules	Vol. 2 No. 2	148
Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray	Vol. 2 No. 2	149
Dihydroergotamine Mesylate 1-mg Troches	Vol. 2 No. 2	150
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories	Vol. 2 No. 2	151
Fentanyl 50-mcg Chewable Gummy Gels	Vol. 2 No. 2	152
Fentanyl 300-mcg/6-mL Inhalation	Vol. 2 No. 2	153
Ketoprofen 10%, Cyclobenzaprine 1% and Lidocaine 5% in Poloxamer Lecithin Organogel	Vol. 2 No. 2	154
Lidocaine 30% Lip Balm	Vol. 2 No. 2	155
Meperidine HCl 50-mg/mL Nasal Solution	Vol. 2 No. 2	156
Morphine Sulfate 25-mg Troche	Vol. 2 No. 2	157
Sumatriptan 5-mg/mL Oral Liquid	Vol. 2 No. 2	158
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel	Vol. 2 No. 2	159
Dexamethasone and Lidocaine Solution for Iontophoresis	Vol. 1 No. 6	410
Ketorolac Solution for Iontophoresis	Vol. 1 No. 6	415
Lidocaine HCl 2% Solution for Iontophoresis	Vol. 1 No. 6	416
Morphine 10-mg Troches	Vol. 1 No. 6	417
Iontophoresis Devices: Clinical Applications for Topical Delivery	Vol. 1 No. 6	420
Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia	Vol. 1 No. 5	325
Hydromorphone HCl 10-, 25-, and 50-mg/mL Injections	Vol. 1 No. 5	327
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection	Vol. 1 No. 5	328
Morphine Sulfate-Bupivacaine HCl Injection	Vol. 1 No. 5	330
Morphine Sulfate 10-, 25-, and 50-mg/mL Injections (Preservative Free)	Vol. 1 No. 5	331
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease	Vol. 1 No. 4	242
Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary	Vol. 1 No. 4	243
Fentanyl and Bupivacaine Injection for Ambulatory Pump Reservoir	Vol. 1 No. 3	178
Piroxicam 2% in an Alcoholic Gel	Vol. 1 No. 3	181
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections	Vol. 1 No. 3	206
Rectal and Stomal Administration of Analgesic Suppositories	Vol. 1 No. 1	12
Morphine Sulfate Slow-Release Suppositories	Vol. 1 No. 1	32
Morphine Suppositories	Vol. 1 No. 1	36

	Instant PDF Download
	Mailed CD